Latest Articles
High Prevalence of Sarcopenia Identified in Patients With Ovarian, Endometrial Cancer - AJMC.com Managed Markets Network
High Prevalence of Sarcopenia Identified in Patients With Ovarian, Endometrial Cancer AJMC.com Managed Markets Network
Published: Feb. 12, 2025, 9:11 p.m.
Incorporating Physical Activity Into Treatment Plans for Patients With Endometrial Cancer - Journal of Clinical Pathways
Incorporating Physical Activity Into Treatment Plans for Patients With Endometrial Cancer Journal of Clinical Pathways
Published: Feb. 12, 2025, 7:33 p.m.
Short- vs Standard-Course Radiation Therapy for Endometrial Cancer - The ASCO Post
Short- vs Standard-Course Radiation Therapy for Endometrial Cancer The ASCO Post
Published: Feb. 12, 2025, 5:48 p.m.
Short-Course Radiation Therapy Effective for Endometrial Cancer Patients | Newswise - Newswise
Short-Course Radiation Therapy Effective for Endometrial Cancer Patients | Newswise Newswise
Published: Feb. 12, 2025, 2:05 a.m.
Short-course, higher dose vaginal brachytherapy for endometrial cancer shown to be effective - News-Medical.Net
Short-course, higher dose vaginal brachytherapy for endometrial cancer shown to be effective News-Medical.Net
Published: Feb. 12, 2025, 1:49 a.m.
Short-course radiation matches standard therapy for endometrial cancer - Medical Xpress
Short-course radiation matches standard therapy for endometrial cancer Medical Xpress
Published: Feb. 11, 2025, 8:52 p.m.
Mettl3/Eed/Ythdc1 regulatory axis controls endometrial receptivity and function - Nature.com
Mettl3/Eed/Ythdc1 regulatory axis controls endometrial receptivity and function Nature.com
Published: Feb. 11, 2025, 8:22 p.m.
Short-Course Radiation Therapy Effective for Endometrial Cancer Patients - University of Utah Health Care
Short-Course Radiation Therapy Effective for Endometrial Cancer Patients University of Utah Health Care
Published: Feb. 11, 2025, 5 p.m.
ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer - Pharmacy Times
ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer Pharmacy Times
Published: Feb. 10, 2025, 2:34 p.m.
SMARCA4-deficient Undifferentiated Carcinoma Co-existing with Primary Endometrial Gastric (or Gastrointestinal) -Type Carcinoma：A Case Report - Frontiers
SMARCA4-deficient Undifferentiated Carcinoma Co-existing with Primary Endometrial Gastric (or Gastrointestinal) -Type Carcinoma：A Case Report Frontiers
Published: Feb. 10, 2025, 2:08 p.m.
Link copied to clipboard!